Biotechnology Assets Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Apr '25 Apr 2, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
Market Capitalization	22	23	12	21	22	80	Upgrade
Market Cap Growth	-6.48%	84.02%	-40.67%	-3.86%	-72.86%	21.99%	Upgrade
Enterprise Value	23	26	19	24	84	120	Upgrade
Last Close Price	0.33	0.40	0.23	0.46	0.56	2.04	Upgrade
PE Ratio	-	14.53	-	-	-	-	Upgrade
Forward PE	-	2.25	2.25	2.25	2.25	34.00	Upgrade
PS Ratio	6.22	5.85	4.20	6.38	7.53	24.79	Upgrade
PB Ratio	2.84	3.50	3.21	4.83	5.67	10.61	Upgrade
P/TBV Ratio	4.67	6.64	-	-	-	96.26	Upgrade
P/FCF Ratio	23.48	-	-	-	2.47	-	Upgrade
P/OCF Ratio	21.49	478.89	-	-	2.47	-	Upgrade
EV/Sales Ratio	6.92	6.74	6.39	7.39	28.95	37.02	Upgrade
EV/EBITDA Ratio	7.08	-	-	-	-	Upgrade
EV/EBIT Ratio	9.73	-	-	-	-	Upgrade
EV/FCF Ratio	25.27	-	-	-	9.51	-	Upgrade
Debt / Equity Ratio	0.34	0.63	2.13	1.90	1.96	8.47	Upgrade
Debt / EBITDA Ratio	-	1.11	-	-	-	-	Upgrade
Debt / FCF Ratio	2.68	-	-	-	0.85	-	Upgrade
Asset Turnover	0.21	0.22	0.15	0.16	0.05	0.04	Upgrade
Inventory Turnover	-	-	-	-	0.05	0.05	Upgrade
Quick Ratio	0.85	1.04	0.88	1.24	0.35	0.77	Upgrade
Current Ratio	0.85	1.04	0.88	1.24	0.35	1.05	Upgrade
Return on Equity (ROE)	-40.78%	30.25%	-47.33%	-73.66%	-29.90%	-23.80%	Upgrade
Return on Assets (ROA)	-7.56%	9.65%	-5.66%	-6.47%	-1.34%	-1.85%	Upgrade
Return on Capital (ROIC)	-11.39%	14.85%	-8.78%	-10.83%	-1.83%	-2.44%	Upgrade
Return on Capital Employed (ROCE)	-	20.80%	-	-	-	-	Upgrade
Earnings Yield	-14.07%	6.88%	-15.64%	-14.39%	-39.52%	-12.57%	Upgrade
FCF Yield	4.26%	-0.10%	-1.17%	-7.26%	40.43%	-28.50%	Upgrade
Buyback Yield / Dilution	-10.39%	-6.50%	-18.82%	-16.39%	-0.04%	0.03%	Upgrade

Updated Oct 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.